As with any product that’s selling on the market, the management of a new drug is hardly complete once it launches. From continuing to learn about new developments in the market to quickly resolving issues that arise, there are plenty of things to keep manufacturers busy with their new treatments. It’s also vital that you stay on top of any new legal developments so that you don’t risk losing any of your state licenses.

It’s also important at the Growth phase to begin considering your loss of exclusivity strategy. How you handle the expiration of your patent can have a tremendous impact on the long-term value of your drug. Some manufacturers don’t begin thinking about this until they get close to that LOE date, but proper, early planning is imperative for maximizing the value of your product through its entire lifecycle.